Cited by 34Mitochondrial Function and PathologyGenomics and Rare DiseasesMetabolism and Genetic Disorders

A homoplasmic mtDNA variant can influence the phenotype of the pathogenic m.7472Cins MTTS1 mutation: are two mutations better than one?

Open access
Swalwell, Helen, Blakely, Emma L, Sutton, Ruth, Tonska, Kasia, Elstner, Matthias, He, Langping, Taivassalo, Tanja, Burns, Dennis K +4 more·2008·European Journal of Human Genetics

Abstract

Mutations in mitochondrial tRNA (mt-tRNA) genes are well recognized as a common cause of human disease, exhibiting a significant degree of clinical heterogeneity. While these differences are explicable, in part, by differences in the innate pathogenicity of the mutation, its distribution and abundance, other factors, including nuclear genetic background, mitochondrial DNA (mtDNA) haplotype and additional mtDNA mutations may influence the expression of mt-tRNA mutations. We describe the clinical, biochemical and molecular findings in a family with progressive myopathy, deafness and diabetes and striking respiratory chain abnormalities due to a well-characterized heteroplasmic mt-tRNA mutation in the mt-tRNA(Ser(UCN)) (MTTS1) gene. In addition to the m.7472Cins mutation, all individuals were homoplasmic for another variant, m.7472A > C, affecting the adjacent nucleotide in the mt-tRNA(Ser(UCN)) structure. In addition to available patient tissues, we have analysed transmitochondrial cybrid clones harbouring homoplasmic levels of m.7472A > C and varying levels of the m.7472Cins mutation in an attempt to clarify the precise role of the m.7472A > C transversion in the underlying respiratory chain abnormality. Evidence from both in vivo and in vitro studies demonstrate that the m.7472A > C is able to modify the expression of the m.7472Cins mutation and would suggest that it is not a neutral variant but appears to cause a biochemical defect by itself, confirming that homoplasmic mtDNA variants can modulate the phenotypic expression of pathogenic, heteroplasmic mtDNA mutations.

Integrity signals

Registry

Crossref · 10.1038/ejhg.2008.65

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Certain nucleotide changes that are not pathogenic per se may modulate the effects of deleterious mtDNA mutations.

    “Also, it has been frequently recognised that certain nucleotide changes that are not pathogenic per se may modulate the effects of deleterious mtDNA mutations [84,85].”

    From Mitochondrial DNA mutations and human disease (2010) · cites this paper as [84]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Swalwell, H., Blakely, E. L., Sutton, R., Tonska, K., Elstner, M., He, L., Taivassalo, T., Burns, D. K., Turnbull, D. M., Haller, R. G., Davidson, M. M., & Taylor, R. W.
Affiliations
  • Newcastle University (GB)
  • Ludwig-Maximilians-Universität München (DE)
  • McGill University (CA)
  • The University of Texas Southwestern Medical Center (US)
  • Texas Health Dallas (US)
  • Columbia University (US)
Corresponding author
Taylor, Robert W
Venue
European Journal of Human Genetics
Published
2008-04-09
Volume
16
Issue
10
Pages
1265-1274
ISSN
  • 1018-4813 (ISSN-L)
  • 1476-5438
OpenAlex
W2070231746
Cited by
34
References
30
Citations by year
2024: 2 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 1 · 2013: 1 · 2012: 7
FWCI
0.96
Type
journal article
Language
en
Open access
Locations
  • European Journal of Human Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • Muscular Dystrophy Association
  • United Mitochondrial Disease Foundation
  • Wellcome Trust (074454)
  • Newcastle upon Tyne Hospitals NHS Foundation Trust
  • Muscular Dystrophy UK
  • National Institutes of Health
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
mitochondrial disease, progressive myopathy, deafness, diabetes mellitus, phenotypic expression, mitochondrial haplotypes
MeSH terms
Aged, Base Sequence, Biological Assay, Clone Cells, Electron Transport Complex IV, DNA Mutational Analysis, DNA, Mitochondrial, Electron Transport, Female, Humans, Male, Middle Aged, Molecular Sequence Data, Mutation, Pedigree, Phenotype, RNA, Transfer, Succinate Dehydrogenase, Protein Biosynthesis, Blotting, Northern, Muscle, Skeletal, Mitochondrial Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review